Atsushi Imagawa
Atsushi Imagawa publishes mostly in Surgery, Pulmonary and Respiratory Medicine and Gastroenterology, on topics such as Gastric Cancer Management and Outcomes, Gastrointestinal Tumor Research and Treatment and Metastasis and carcinoma case studies.
- World rank
- #1,904,386 of 7,710,434 ranked researchers
- Rank in Japan
- #33,768 of 383,136
- Works
- 95
- Citations
- 2k
- Citations per work
- 21.4
What does Atsushi Imagawa research?
Atsushi Imagawa's work is mostly in Medicine (77%), Biochemistry, Genetics and Molecular Biology (2%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences7477.4%
- Medicine7477.4%
- Everything else2020.7%
- Life Sciences21.9%
- 1Surgery28% of their works
- 2Pulmonary and Respiratory Medicine28% of their works
- 3Gastroenterology11% of their works
- 4Oncology7% of their works
- 5Pathology and Forensic Medicine3% of their works
- 6Molecular Biology2% of their works
Research topics
- Gastric Cancer Management and Outcomes
- Gastrointestinal Tumor Research and Treatment
- Metastasis and carcinoma case studies
- Esophageal Cancer Research and Treatment
- Helicobacter pylori-related gastroenterology studies
- Gastrointestinal disorders and treatments
- Esophageal and GI Pathology
- Pancreatic and Hepatic Oncology Research
Which keywords describe Atsushi Imagawa's research?
The keywords of their largest research topics: Endoscopic Resection, Gastric Cancer, Chemotherapy, Lymph Node Dissection, Molecular Characterization, Epidemiology, Neoadjuvant Therapy and Imatinib Mesylate.
- Pancreatic Cancer
- Endoscopic Stenting
- Intussusception
- Helicobacter pylori
- Esophageal Carcinoma
- Metastatic Carcinomas
- Imatinib Mesylate
- Epidemiology
- Lymph Node Dissection
- Gastric Cancer
- Endoscopic Resection
- Chemotherapy
- Molecular Characterization
- Neoadjuvant Therapy
- Lung Tumors
- Sunitinib
- Preoperative Chemoradiotherapy
- Inflammation
- Meckel's Diverticulum
- Esophageal Perforation
- Surgical Complications
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Endoscopic Resection532 topics
- Gastric Cancer502 topics
- Chemotherapy442 topics
- Lymph Node Dissection381 topic
- Molecular Characterization381 topic
- Epidemiology252 topics
- Neoadjuvant Therapy212 topics
- Imatinib Mesylate201 topic
- Lung Tumors201 topic
- Metastatic Carcinomas201 topic
- Sunitinib201 topic
- Esophageal Carcinoma151 topic
- Preoperative Chemoradiotherapy151 topic
- Helicobacter pylori121 topic
- Inflammation121 topic
- Intussusception101 topic
- Meckel's Diverticulum101 topic
- Endoscopic Stenting81 topic
- Esophageal Perforation81 topic
- Pancreatic Cancer61 topic
- Surgical Complications61 topic
Where does Atsushi Imagawa work?
Atsushi Imagawa's main affiliation in the publication record is Mito Saiseikai General Hospital, Japan.
How many publications and citations does Atsushi Imagawa have?
OpenAlex counts 95 works and 2,034 citations for Atsushi Imagawa, an h-index of 17, ranking #1,904,386 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Atsushi Imagawa. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.